FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

16450211000001105: Zindaclin 1% gel (Lexon (UK) Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 04-Jan 2010. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
57577701000001116 Zindaclin 1% gel (Lexon (UK) Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
57577801000001113 Zindaclin 1% gel (Lexon (UK) Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Zindaclin 1% gel (Lexon (UK) Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Zindaclin 1% gel (Lexon (UK) Ltd) Has NHS dm+d (dictionary of medicines and devices) parallel import indicator Parallel Import - supplier (qualifier value) false Inferred relationship Existential restriction modifier
Zindaclin 1% gel (Lexon (UK) Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Zindaclin 1% gel (Lexon (UK) Ltd) Has NHS dm+d (dictionary of medicines and devices) parallel import indicator Parallel import true Inferred relationship Existential restriction modifier
Zindaclin 1% gel (Lexon (UK) Ltd) Is a Product containing precisely clindamycin (as clindamycin phosphate) 10 milligram/1 gram conventional release cutaneous gel true Inferred relationship Existential restriction modifier
Zindaclin 1% gel (Lexon (UK) Ltd) Has active ingredient Clindamycin false Inferred relationship Existential restriction modifier
Zindaclin 1% gel (Lexon (UK) Ltd) Has manufactured dose form Cutaneous AND/OR transdermal dosage form false Inferred relationship Existential restriction modifier
Zindaclin 1% gel (Lexon (UK) Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Zindaclin 1% gel (Lexon (UK) Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Zindaclin 1% gel (Lexon (UK) Ltd) Has specific active ingredient Clindamycin phosphate true Inferred relationship Existential restriction modifier
Zindaclin 1% gel (Lexon (UK) Ltd) Has dispensed dose form Gel true Inferred relationship Existential restriction modifier
Zindaclin 1% gel (Lexon (UK) Ltd) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Clindamycin true Inferred relationship Existential restriction modifier
Zindaclin 1% gel (Lexon (UK) Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Zindaclin 1% gel (Lexon (UK) Ltd) Is a Zindaclin true Inferred relationship Existential restriction modifier
Zindaclin 1% gel (Lexon (UK) Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Zindaclin 1% gel (Lexon (UK) Ltd) Has basis of strength substance Clindamycin true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Zindaclin 1% gel (Lexon (UK) Ltd) 30 gram Has AMP True Zindaclin 1% gel (Lexon (UK) Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start